Mobile

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety of MK-0431 Monotherapy in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Inadequate Glycemic Contr...

Update Il y a 5 ans
Reference: EUCTR2004-002160-22

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety of MK-0431 Monotherapy in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Inadequate Glycemic Control

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

In patients with type 2 diabetes mellitus and chronic renal insufficiency with inadequate glycemic control Primary: To assess the safety and tolerability of MK-0431 after 12 weeks.

Inclusion criteria

  • Type 2 diabetes mellitus,Chronic Renal Insufficiency [MedDRA classification code: 10050441]

Links